Literature DB >> 1797100

Effect of bromocriptine in patients with apomorphine-responsive erectile impotence: an open study.

S Lal1, M E Kiely, J X Thavundayil, J D Stewart, P Assalian, C F Ackman.   

Abstract

An open pilot study was undertaken to investigate the therapeutic effect of the dopaminergic agent, bromocriptine (BC), in impotent patients who developed an erectile response to the dopamine receptor agonist, apomorphine. Eight out of 17 patients reported improvement in ability to obtain an erection; five of these 8 subjects were able to achieve penetration. The optimum dose of BC was 2.5 - 11.25 mg/day. A double-blind placebo-controlled study is merited.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1797100      PMCID： PMC1188363     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


  27 in total

1.  Effect of apomorphine on penile tumescence in men with psychogenic impotence.

Authors:  R T Segraves; M Bari; K Segraves; P Spirnak
Journal:  J Urol       Date:  1991-06       Impact factor: 7.450

2.  Bromocriptine in impotence.

Authors:  A J Cooper
Journal:  Lancet       Date:  1977-09-10       Impact factor: 79.321

3.  Treatment of alcoholism with Dent's oral apomorphine method.

Authors:  E K Schlatter; S Lal
Journal:  Q J Stud Alcohol       Date:  1972-06

Review 4.  Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems.

Authors:  J L Waddington
Journal:  Biochem Pharmacol       Date:  1986-11-01       Impact factor: 5.858

5.  Apomorphine and psychopathology.

Authors:  S Lal; C E De la Vega
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

6.  Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects.

Authors:  S Lal; D Ackman; J X Thavundayil; M E Kiely; P Etienne
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1984       Impact factor: 5.067

Review 7.  Apomorphine in the evaluation of dopaminergic function in man.

Authors:  S Lal
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1988       Impact factor: 5.067

8.  Apomorphine: clinical studies on erectile impotence and yawning.

Authors:  S Lal; Y Tesfaye; J X Thavundayil; T R Thompson; M E Kiely; N P Nair; A Grassino; B Dubrovsky
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1989       Impact factor: 5.067

9.  Effect of methysergide and pimozide on apomorphine-induced growth hormone secretion in men.

Authors:  S Lal; H Guyda; S Bikadoroff
Journal:  J Clin Endocrinol Metab       Date:  1977-04       Impact factor: 5.958

10.  Long-term treatment of galactorrhoea and hypogonadism with bromocriptine.

Authors:  M O Thorner; A S McNeilly; C Hagan; G M Besser
Journal:  Br Med J       Date:  1974-05-25
View more
  3 in total

Review 1.  Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?

Authors:  L Dépatie; S Lal
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

Review 2.  Dopamine, Erectile Function and Male Sexual Behavior from the Past to the Present: A Review.

Authors:  Maria Rosaria Melis; Fabrizio Sanna; Antonio Argiolas
Journal:  Brain Sci       Date:  2022-06-24

3.  Effect of blood sampling on apomorphine-induced penile tumescence in erectile impotence: a case report.

Authors:  M E Kiely; J X Thavundayil; S Lal
Journal:  J Psychiatry Neurosci       Date:  1995-05       Impact factor: 6.186
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.